Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Total article views   Abstract views HTML views PDF downloads Totals
2,350 Dovepress* 1,667 432+ 682 2,099
PubMed Central* 0 251 116 251
Totals 1,667 683 798 2,350
*Since 3 July 2019
+Since July 2016

View citations on PubMed Central and Google Scholar